Background m6A regulators have important roles in a variety of autoimmune diseases, but
their potential function in scleroderma, a refractory connective tissue disease, remains …

Background Psoriasis is a chronic immune-mediated inflammatory disease. N6-
methyladenosine (m6A) is involved in numerous biological processes in both normal and …

Aim: To explore the N6-methyladenosine (m6A) methylation of mRNAs and its roles in a
mouse model of scleroderma. Materials & methods: To evaluate whether the mouse model …

Abstract N6-methyladenosine (m6A) is one kind of important epigenetic modification pattern
which is extensively involved in immune regulation. The development and progression of …

Background Disruption of N6 methyl adenosine (m6A) modulation hampers gene
expression and cellular functions, leading to various illnesses. However, the role of m6A …

One of the most prevalent posttranscriptional modifications of eukaryotic mRNA is the RNA
N6-methyladenosine (m6A) regulator, which plays a significant role in various illnesses. The …

Background Few studies have been reported the potential role of N6-methyladenosine
(m6A) modification in osteoarthritis (OA). We investigated the patterns of m6A modification in …

Abstract Background N6-methyladenosine (m6A) is a universal RNA modification pattern
regulated by multiple m6A regulators. In osteoarthritis (OA), m6A regulators influence …

Systemic lupus erythematosus (SLE) is a prototypical systemic autoimmune disease of
unknown etiology. The epigenetic regulation of N6-methyladenosine (m6A) modification in …

Background Systemic Lupus Erythematosus (SLE), a prototypical autoimmune disorder,
presents a challenge due to the absence of reliable biomarkers for discerning organ-specific …